@article{3196673,
    title = "Five-year overall survival (OS) in COLUMBUS: A randomized phase 3 trial
of encorafenib plus binimetinib versus vemurafenib or encorafenib in
patients (pts) with BRAF V600-mutant melanoma.",
    author = "Dummer, Reinhard and Flaherty, Keith and Robert, Caroline and Arance, and Ana Maria and De Groot, Jan Willem and Garbe, Claus and Gogas, Helen and and Gutzmer, Ralf and Krajsova, Ivana and Liszkay, Gabriella and Loquai, and Carmen and Mandala, Mario and Schadendorf, Dirk and Yamazaki, Naoya and and Pickard, Michael D. and Zohren, Fabian and Edwards, Michelle L. and and Ascierto, Paolo Antonio",
    journal = "World Journal of Clinical Oncology",
    year = "2021",
    volume = "39",
    number = "15, S",
    publisher = "Lippincott, Williams & Wilkins",
    doi = "10.1200/JCO.2021.39.15_suppl.9507"
}